Pharmacological treatments for preventing epilepsy following traumatic head injury

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 8, 2015, Pages

  Thompson, Kara ^a   Pohlmann Eden, Bernhard ^b   Campbell, Leslie A ^a   Abel, Hannah ^b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; LEVETIRACETAM; MAGNESIUM SULFATE; NEUROPROTECTIVE AGENT; PHENYTOIN; PLACEBO; VALPROIC ACID; ETIRACETAM; PIRACETAM;

AGE DISTRIBUTION; ALL CAUSE MORTALITY; CLINICAL EFFECTIVENESS; EPILEPSY; EVIDENCE BASED MEDICINE; HUMAN; INJURY SEVERITY; INTENTION TO TREAT ANALYSIS; NEUROPROTECTION; POPULATION RESEARCH; PREVENTIVE MEDICINE; PRIORITY JOURNAL; RASH; REVIEW; SYSTEMATIC REVIEW; TRAUMATIC BRAIN INJURY; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; ADULT; ANALOGS AND DERIVATIVES; CAUSE OF DEATH; CHILD; COMPLICATION; HEAD INJURY; META ANALYSIS; MORTALITY; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ADULT; ANTICONVULSANTS; CARBAMAZEPINE; CAUSE OF DEATH; CHILD; CRANIOCEREBRAL TRAUMA; EPILEPSY; HUMANS; MAGNESIUM SULFATE; NEUROPROTECTIVE AGENTS; PHENYTOIN; PIRACETAM; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VALPROIC ACID;

EID: 84991243766     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD009900.pub2     Document Type: Review

References (112)

1. Glotzner FL, Haubitz I, Miltner F, Kapp G, Pflughaupt K-W. Seizure prevention using carbamazepine following severe brain injuries [Anfallsprophylaxe mit Carbamazepin nach schweren Schadelhirnverletzungen]. Neurochirurgia 1983;26(3):66-79.
2. Manaka S. Cooperative prospective study on posttraumatic epilepsy: risk factors and the effect of prophylactic anticonvulsant. Japanese Journal of Psychiatry and Neurology 1992;46(2):311-5.
3. Harris P, Kalbag RM, McQueen JK, Blackwood DHR, Johnson AL. The incidence and the possible pharmacological prophylaxis of post-traumatic epilepsy [abstract]. Acta Neurochirurgica 1984;70(1-2):132.
4. McQueen JK, Blackwood DHR, Harris P, Kalbag RM, Johnson AL. Low risk of late post-traumatic seizures following severe head injury: implications for clinical trials of prophylaxis. Journal of Neurology, Neurosurgery, and Psychiatry 1983;46(10):899-904.
5. Lauxerois M, Pechadre JC, Colnet G, Commun C, Bonnard M. Hydantoins in the prevention of early posttraumatic epileptic crises [Prevention des crises d'epilepsie posttraumatiques precoces par les hydantoines]. Epilepsies 1990;2(1):5-10.
6. Pechadre JC, Lauxerois M, Colnet G, Commun C, Bonnard M, Gilbert J, et al. Prevention of late post-traumatic epilepsy by phenytoin in severe brain injuries, 2 years' follow-up [Prevention de l'epilepsie post-traumatique tardive par phenytoine dans les traumatismes craniens graves, suivi durant 2 ans]. Presse Medicale 1991;20(18):841-5.
7. NCT00618436. Assess the safety and efficacy of a seizure medication, levetiracetam (LEV; Keppra), in neuroscience intensive care unit patients. www.clinicaltrials.gov/ct2/show/NCT00618436 (accessed 11 February 2014).
8. Steinbaugh LA, Lindsell CJ, Shutter LA, Szaflarski JP. Initial EEG predicts outcomes in a trial of levetiracetam vs. fosphenytoin for seizure prevention. Epilepsy & Behavior 2012;23(3):280-4.
9. Szaflarski JP, Sangha KS, Lindsell CJ, Shutter LA. Prospective, randomized, single-blinded comparative trial of intravenous levetiracetam versus phenytoin for seizure prophylaxis. Neurocritical Care 2010;12(2):165-72.
10. Haltiner AM, Newell DW, Temkin NR, Dikmen SS, Winn HR. Side effects and mortality associated with use of phenytoin for early posttraumatic seizure prophylaxis. Journal of Neurosurgery 1999;91(4):588-92.
11. Temkin NR, Dikmen SS, Keihm J, Chabal S, Winn HR. Does phenytoin prevent posttraumatic seizures -1-year follow-up results of a randomized double-blind-study in 407 patients [abstract]. Journal of Neurosurgery 1989;70(2):314A-315A.
12. Temkin NR, Dikmen SS, Wilensky AJ, Keihm J, Chabal S, Winn HR. A randomized double-blind study of phenytoin for the prevention of post-traumatic seizures. New England Journal of Medicine 1990;323(8):497-502.
13. NCT00004817. Phase III double blind trial of valproate sodium for prophylaxis of post traumatic seizures. www.clinicaltrials.gov/ct2/show/record/NCT00004817 (accessed 11 February 2014).
14. Temkin NR, Dikmen SS, Anderson GD, Wilensky AJ, Holmes, Cohen W, et al. Valproate therapy for prevention of posttraumatic seizures: a randomized trial. Journal of Neurosurgery 1999;91(4):593-600.
15. Temkin NR, Anderson GC, Winn HR, Ellenbogen RG, Britz GW, Schuster J, et al. Magnesium sulfate for neuroprotection after traumatic brain injury: a randomized controlled trial. Lancet Neurology 2007;6(1):29-38.
16. Young B, Rapp RP, Norton JA, Haack D, Tibbs PA, Bean JB. Failure of prophylactically administered phenytoin to prevent early posttraumatic seizures. Journal of Neurosurgery 1983;58(2):231-5.
17. Young B, Rapp RP, Norton JA, Haack D, Tibbs PA, Bean JR. Failure of prophylatically administered phenytoin to prevent late posttraumatic seizures. Journal of Neurosurgery 1983;58(2):236-41.
18. Young B, Rapp RP, Norton JA, Haack D, Walsh JW. Failure of prophylatically administered to prevent post-traumatic seizures in children. Child's Brain 1983;10(3):1985-92.
19. Young KD, Okada PJ, Sokolove PE, Palchak MJ, Panacek EA, Baren JM, et al. A randomized, double-blinded, placebo-controlled trial of phenytoin for the prevention of early posttraumatic seizures in children with moderate to severe blunt head injury. Annals of Emergency Medicine 2004;43(4):435-46.
20. Anderson GD, Lin Y, Temkin NR, Fischer JH, Winn RH. Incidence of intravenous site reactions in neurotrauma patients receiving valproate or phenytoin. Annals of Pharmacotherapy 2000;34(6):697-702.
21. Anderson GD, Temkin NR, Chandler WL, Winn HR. Effect of valproate on hemostatic function in patients with traumatic brain injury. Epilepsy Research 2003;57(2-3):111-19.
22. Asikainen I, Kaste M, Sarna Seppo. Early and late posttraumatic seizures in traumatic brain injury rehabilitation patients: brain injury factors causing late seizures and influence of seizures on long-term outcome. Epilepsia 1999;40(5):584-9.
23. Carter D, Askari R, Frawley B, Rogers S. Evaluation of the use of phenytoin and levetiracetam for seizure prophylaxis in patients with traumatic brain injury. Critical Care Medicine 2009;37(12 Suppl):A77, Abstract no: 185.
24. Chiaretti A, De Benedictis R, Polidori G, Piastra M, Iannelli A, Di Rocco C. Early post-traumatic seizures in children with head injury. Child's Nervous System 2000;16(12):862-6.
25. Coplin WM, Rhoney DH, Rebuck JA, Clements EA, Cochran MS, O'Neil BJ. Randomized evaluation of adverse events and length-of-stay with routine emergency department use of phenytoin or fosphenytoin. Neurological Research 2002;24(8):842-8.
26. De Santis A, Sganzeria E, Spagnoll D, Bello L, Tiberio F. Risk factors for late posttraumatic epilepsy. Acta Neurochirurgica. Supplementum 1992;55:64-7.
27. De Santis A, Bello L, Spagnoli D, Sganzeria E. Antiepileptic prophylaxis in head injured patients. Bollettino Lega Italiana contro l'Epilessia 1992;no. 79-80:305-6.
28. De Santis A, Lanterma AL, Ceccarelli G, Kouhpouros N, Villani RM. Role of PB in preventing late PTE [abstract]. Epilepsia 1998;39(Suppl s2):48.
29. Dikmen SS, Temkin NR, Miller B, Machamer J, Winn HR. Neurobehavioral effects of phenytoin prophylaxis of posttraumatic seizures. JAMA 1991;265(10):1271-7.
30. Dikmen SS, Temkin NR, Winn HR. Neurobehavioral effects of phenytoin prophylaxis in posttraumatic seizures: a double-blind comparison [abstract]. Epilepsia 1989;30(5):667.
31. Dikmen SS, Machamer JE, Winn HR, Temkin NR. Neuropsychological outcome at 1-year post head-injury. Neuropsychology 1995;9(1):80-90.
32. Dikmen SS, Machamer JE, Winn HR, Anderson DG, Temkin NR. Neuropsychological effects of valproate in traumatic brain injury: a randomized trial. Neurology 2000;54(4):895-902.
33. Dizdarevic K, Hamdan A, Omerhodzic I, Kominlija-Smajic E. Modified Lund concept versus cerebral perfusion pressure-targeted therapy: a randomised controlled study in patients with secondary brain ischaemia. Clinical Neurology and Neurosurgery 2012;114(2):142-8.
34. Dolati P, Akhtar SM, Ziabary SM. Determination of the efficacy of phenytoin on prevention of late post-traumatic seizure. Journal of Neurology 2012;259(1):S15.
35. Englander J, Bushnik T, Duong TT, Cifu DX, Zafonte R, Wright J, et al. Analyzing risk factors for late posttraumatic seizures: a prospective, multicenter investigation. Archives of Physical Medicine & Rehabilitation 2003;84(3):365-73.
36. Formisano R, Barba C, Buzzi MG, Newcomb-Fernadez J, Menniti-Ippolito F, Zafonte R, et al. The impact of prophylactic treatment on post-traumatic epilepsy after severe traumatic brain injury. Brain Injury 2007;21(5):499-504.
37. Glotzner FL. Epilepsy prophylaxis with carbamazepine in severe brain injury [abstract]. Epilepsia 1998;39(Suppl 2):48.
38. Haltiner AM, Temkin NR, Dikmen SS. Risk of seizure recurrence after the first late posttraumatic seizure. Archives of Physical Medicine & Rehabilitation 1997;78(8):835-40.
39. Haltiner AM, Temkin NR, Winn HR, Dikmen SS. The impact of posttraumatic seizures on 1-year neuropsychological and psychosocial outcome of head injury. Journal of the International Neuropsychological Society 1996;2(6):494-504.
40. Holland JP, Stapleton SR, Moore AJ, Marsh HT, Uttley D, Bell BA. A randomised double blind study of sodium valproate for the prevention of seizures in neurosurgical patients [abstract]. Journal of Neurology, Neurosurgery, and Psychiatry 1995;58(1):116.
41. Inaba K, Menaker J, Branco BC, Gooch J, Okoye OT, Herrold J, et al. A prospective multicenter comparison of levetiracetam versus phenytoin for early posttraumatic seizure prophylaxis. Journal of Trauma and Acute Care Surgery 2013;74(3):766-71.
42. Jallon P, Ducolomnier A, Boucetta M, Desgeorges M. Epidemiological approach of post-traumatic epilepsy [L'epilepsie post-traumatique approche epidemiologique]. Revue Internationale des Services de Sante des Armees de Terre, de Mer et de l'Air 1994;56(6):505-12.
43. Japan Follow-up Group for Posttraumatic Epilepsy. [The factors influencing posttraumatic epilepsy: a multicentric cooperative study]. No shinkei geka [Neurological Surgery] 1991;19(12):1151-9. [PUBMED: 1766540]
44. Johnson D, Rottman K, De Los Santos M. Retrospective comparison of the cost and effectiveness of levetiracetam versus phenytoin for seizure prophylaxis. Critical Care Medicine 2009;37(12 Suppl):A475, Abstract no: 968.
45. Jones KE, Puccio AM, Harshman KJ, Falcione B, Benedict N, Jankowitz BT, et al. Levetiracetam versus phenytoin for seizure prophylaxis in severe traumatic brain injury. Neurosurgery Focus 2008;25(4):1-5.
46. Kieslich M, Born A, Jacobi G. Anticonvulsive prophylaxis of posttraumatic epilepsy in childhood [Antikonvulsive Prophylaxe der posttraumatischen Epilepsie im Kindersalter]. Aktuelle Neurologie 2001;28(7):313-8.
47. Kirmani BF, Mungall D, Ling G. Role of intravenous levetiracetam in seizure prophylaxis of severe traumatic brain injury patients. Fontiers in Neurology 2013;4:1-4.
48. Klein P, Herr D, Pearl PL, Sandoval F, Trzcinski S, Nogay C, et al. Safety, tolerability and pharmacokinetics of levetiracetam in patients with acute traumatic brain injury with high risk [abstract]. Epilepsia 2008;49(Suppl s7):81, Abstract no: 1.187.
49. Klein P, Herr D, Pearl PL, Natale J, Levine Z, Nogay C, et al. Results of phase 2 safety and feasibility study of treatment with levetiracetam for prevention of posttraumatic epilepsy. Archives of Neurology 2012;69(10):1290-5.
50. Klein P, Herr D, Pearl PL, Natale J, Levine Z, Nogay C, et al. Results of phase II pharmacokinetic study of levetiracetam for prevention of post-traumatic epilepsy. Epilepsy & Behavior 2012;24:457-61.
51. Kobayashi M. Cooperative multicentre study on postraumatic epilepsy. Brain and Nerve 1997;49(8):723-7.
52. Lopes J, Santos A, Martins da Silva A. Post traumatic epilepsy: a follow-up of 20 years. Epilepsia 2009;50(Suppl 4):160, Abstract no: E411.
53. Maas AIR, Murry G, Henney H 3rd, Kassem N, Legrand V, Mangelus M, et al. Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial. Lancet Neurology 2006;5(1):38-45.
54. Meo R, Bilo L, de Leva MF. Levetiracetam in patients with post-traumatic epilepsy: observations in a case series. Epilepsia 2009;50(Suppl. 11):106, Abstract no: 1.215.
55. Murri L, Parenti G, Bonuccelli U, Lenzi B, Del Tacca M. Phenobarbital prophylaxis of post traumatic epilepsy. Italian Journal of Neurological Sciences 1980;1(4):225-30.
56. Murri L, Arrigo A, Bonuccelli U, Rossi G, Parenti G. Phenobarbital in the prophylaxis of late posttramatic seizures. Italian Journal of Neurological Sciences 1992;13(9):755-60.
57. Nakamura N. Cooperative multicentre study on postraumatic epilepsy. Brain and Nerve 1995;47(12):1170-6.
58. Nakamura N, Ishijima B, Mayanagi Y, Manaka S. A randomized controlled trial of zonisamide in postoperative epilepsy: a report of the cooperative group study. Japanese Journal of Neurosurgery 1999;8(10):647-56.
59. NCT00566046. Prospective, randomized, double-blind study assessing the effects of levetiracetam compared to placebo in the prevention of early epileptic seizures and late epilepsy in patients with severe traumatic brain injury. www.clinicaltrials.gov/ct/show/NCT00566046 (accessed 11 February 2014).
60. NCT00598923. Preventing epilepsy after traumatic brain injury with topiramate (PEPTO). www.clinicaltrials.gov/ct/show/NCT00598923 (accessed 11 February 2014).
61. NCT01110187. A pilot study of NSICU assessment of seizure prophylaxis with lacosamide. clinicaltrials.gov/show/NCT01110187 (accessed 11 February 2014).
62. North BJ, Hanieh A, Challen RG, Penhall RK, Hann CS, Frewin DB. Postoperative epilepsy: a double-blind trial of phenytoin after craniotomy. Lancet 1980;1(8165):384-6.
63. North BJ, Penhall RK, Hanieh A, Frewin DB, Taylor WB. Phenytoin and postoperative epilepsy: a double-blind study. Journal of Neurosurgery 1983;58(5):672-7.
64. Ohman J, Braakman R, Legout V, Traumatic Brain Injury Study Group. Repinotan (BAY x 3702): a 5HT1A agonist in traumatically brain injured patients. Journal of Neurotrauma 2001;18(12):1313-21.
65. Ohno K, Maehara T, Ichimura K, Suzuki R, Hirakawa K. Low incidence of seizures in patients with chronic subdural haematoma. Journal of Neurology, Neurosurgery, and Psychiatry 1993;56(11):1231-3.
66. Pearl PL, Tsuchida T, McCarter R, Pettiford JM, Sandoval F, Trzcinski S, et al. Results of phase II NIH study of levetiracetam for the prevention of pediatric post-traumatic epilepsy (PTE). Annals of Neurology 2009;66(Suppl S1):S122, Abstract no: 81.
67. Pearl PL, McCarter R, McGavin CL, Yu Y, Sandoval F, Trzcinsky S, et al. Results of phase II levetiracetam trial following head injury in children at risk for posttraumatic epilepsy. Epilepsia 2013;59(9):135-7.
68. Penry JK, White BG, Bracket CE. A controlled prospective study of the pharmacologic prophylaxis of posttraumatic epilepsy. Neurology 1979;29(4):600-1.
69. Popek K, Musil F. Clinical attempt to prevent post-traumatic epilepsy following severe brain injuries in adults [Klindky pokus o prevenci posttraumaticke epidelpsie po tezkych zranenick mozku u dospelych]. Casopis Lekaru Ceskych 1969;108(5):133-47. [PUBMED: 4976099]
70. Popek K. Preventative treatment of post-traumatic epilepsy following severe brain injury. Closing report summarizing results of the research done in the framework of the state research plan for the years 1965-1969; edited by Z. Servit [Prevence posttraumaticke eplilepsi po tezkych zranenich mozku]. Ceskoslovenska Neurologie 1972;35(4):169-74. [PUBMED: 5044144]
71. Richard I, Francois C, Louis F, de la Greve M, Perrouin-Verbe B, Mathe JF. Post-traumatic epilepsy: retrospective analysis of 90 severe traumatic brain injuries [Epilepsie post-traumatique: analyse retrospective d'une serie de 90 traumatismes craniens graves]. Annales de Readaptation et de Medecine Physique 1998;41(7):409-15.
72. Schutze M, Dauch AW, Guttinger M, Hampel-Christiansen M, Firsching R. Risk factors for posttraumatic fits and epilepsies [Riskofaktoren fur posttraumatische Anfalle und Epilepsie]. Zentralblatt fur Neurochirurgie 1999;60(4):163-7.
73. Servit Z, Musil F. Prophylactive treatment of post traumatic epilepsy: results of a long-term follow-up in Czechoslovakia. Epilepsia 1981;22(3):315-20.
74. Smith KR Jr, Goulding PM, Wilderman D, Goldfader PR, Holterman-Hommes P, Wei F. Neurobehavioral effects of phenytoin and carbamazepine in patients recovering from brain trauma: a comparative study. Archives of Neurology 1994;51(7):653-60.
75. Steinbaugh LA, Lindsell CJ, Shutter LA, Szaflarski JP. Initial EEG predicts outcomes in a trial of levetiracetam vs. fosphenytoin for seizure prevention. Epilepsy & Behavior 2012;23:280-4.
76. Szaflarski JP, Meckler JM, Szaflarski M, Shutter LA, Privitera MD, Yates SL. Levetiracetam use in critically ill patients. Neurocritical Care 2007;7(2):140-7. [PUBMED: 17607530]
77. Temkin NR. Risk factors for posttraumatic seizures in adults. Epilepsia 2003;44(Suppl s10):18-20.
78. Thapa A, Chandra SP, Sinha S, Sreenivas V, Sharma BS, Tripathi M. Post-traumatic seizures -a prospective study from a tertiary level trauma center in a developing country. Seizure 2010;19(4):211-6.
79. Tomovic M, Ilic T, Mihajlovic M, Minic LJ, Jovicic A. Prophylaxis or therapy for patients with open cranio-cerebral trauma in order to prevent post-traumatic epilepsy. Journal of the Neurological Sciences 1997;150(Suppl 1):S214, Abstract no: 4-06-07.
80. Van den Berghe G, Schoonheydt K, Becx P, Bruyninckx F, Wouters PJ. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 2005;64(8):1348-53. [PUBMED: 15851721]
81. Virant-Young D, Alexander R, Umstead G, Savoy-Moore R, Himes D, Nikolavsky M, et al. Retrospective analysis of phenytoin and levetiracetam for seizure prophylaxis after traumatic brain injury. Critical Care Medicine 2009;37(12 suppl):A443, Abstract no: 904.
82. Watson NF, Barber JK, Doherty MJ, Miller JW, Temkin NR. Does glucocorticoid administration prevent late seizures after head injury?. Epilepsia 2004;45(6):690-4.
83. Wohns RNW, Wyler AR. Prophylactic phenytoin in severe head injuries. Journal of Neurosurgery 1979;51(4):507-9. [PUBMED: 113510]
84. Bertch KE, Norton JA, Young AB, Rapp RP, Tibbs PA. A comparative study of laboratory parameters in head-injured patients receiving either phenytoin or placebo for 24 months. Drug Intelligence & Clinical Pharmacy 1985;19(7-8):561-6.
85. Rapp RP, Norton JA, Young B, Tibbs PA. Cutaneous reactions in head-injured patients receiving phenytoin for seizure prophylaxis. Neurosurgery 1983;13(3):272-5.
86. Use of Biperiden for the Prevention of Post-Traumatic Epilepsy. Ongoing study 2013.
87. Allopregnanolone for the Treatment of Traumatic Brain Injury. Ongoing study 2013.
88. Traumatic neuroprotection and epilepsy prevention of Valproate acid. Ongoing study 2013.
89. Annegers JF, Hauser WA, Coan SP, Rocca WA. A population-based study of seizures after traumatic brain injuries. New England Journal of Medicine 1998;338(1):20-4.
90. Beghi E. Overview of studies to prevent post traumatic epilepsy. Epilepsia 2003;44(Suppl 10):21-6.
91. Bertch KE, Norton JA, Young AB, Rapp RP, Tibbs PA. A comparative study of laboratory parameters in head-injured patients receiving either phenytoin or placebo for 24 months. Drug Intelligence & Clinical Pharmacy 1985;19(7-8):561-6.
92. Brandt C, Heile A, Potschka H, Stoehr T, Loscher W. Effects of the novel antiepileptic drug lacosamide on the development of amygdala kindling in rats. Epilepsia 2006;47(11):1803-9.
93. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7(3):177-88.
94. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
95. Jennett B, Teasdale G. Management of head injuries. Philadelphia: F.A. Davis, 1981.
96. Kirkham JJ, Dwan KM, Altman DG, Gamble C, Dodd S, Smyth R, et al. The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews. BMJ 2010;340:c365. [DOI: http://dx.doi.org/10.1136/bmj.c365]
97. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
98. Löscher W. Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy. Epilepsy Research 2002;50(1-2):105-23. [PUBMED: 12151122]
99. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815-34.
100. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
101. Schünemann HG, Oxman AD, Higgins JPT, Vist GE, Glasziou P, Guyatt GH. Chapter 11: Presenting results and summary of findings tables. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
102. Slemmer JE, Shacka JJ, Sweeney MI, Weber JT. Antioxidants and free radical scavengers for the treatment of stroke, traumatic brain injury and aging. Current Medicinal Chemistry 2008;15(4):404-14.
103. Teasell R, Bayona N, Marshall S, Cullen N, Bayley M, Chundamala J, et al. A systematic review of rehabilitation of moderate to severe acquired brain injuries. Brain Injury 2007;21(2):107-12.
104. Temkin N. Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: meta-analysis of controlled trials. Epilepsia 2001;42(4):515-24.
105. Temkin N. Preventing and treating posttraumatic seizures: the human experience. Epilepsia 2009;50(Suppl 2):10-13.
106. Whitehead A, Whitehead J. A general parametric approach to the meta-analysis of randomised clinical trials. Statistics in Medicine 1991;10(11):1665-77.
107. Williamson PR, Tudur Smith C, Hutton JL, Marson AG. Aggregate data meta-analysis with time to event outcomes. Statistics in Medicine 2002;21(22):3337-51.
108. Willmore LJ, Ueda Y. Posttraumatic epilepsy: hemorrhage, free radicals and the molecular regulation of glutamate. Neurochemical Research 2009;34(4):688-97.
109. Wyllie E. Wyllie's Treatment of Epilepsy. 5th Edition. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins, 2010.
110. Young B, Rapp R, Brooks WH, Madauss W, Norton JA. Posttraumatic epilepsy prophylaxis. Epilepsia 1979;20(6):671-81.
111. Schierhout G, Roberts IG. Anti-epileptic drugs for preventing seizures following acute traumatic brain injury. Cochrane Database of Systematic Reviews 2001, Issue 4. [DOI: 10.1002/14651858.CD000173]
112. Thompson K, Pohlmann-Eden B, Campbell LA. Pharmacological treatments for preventing epilepsy following traumatic head injury. Cochrane Database of Systematic Reviews 2012, Issue 6. [DOI: 10.1002/14651858.CD009900]